Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boback Ziaeian

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
JACC. Heart Failure|October 4, 2024
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2021Manyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian
JACC. Asia|November 7, 2022
Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection FractionNicholas K Brownell, Boback Ziaeian, Gregg C Fonarow
JACC. Heart Failure|October 17, 2017
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future DirectionsJeffrey J Hsu, Boback Ziaeian, Gregg C Fonarow
JAMA Cardiology|February 10, 2021
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2017Manyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian
Current Diabetes Reports|January 25, 2016
The 2013 ACC/AHA Cholesterol Treatment Guidelines: Applicability to Patients with DiabetesBoback Ziaeian, John Dinkler, Yuanlin Guo, et al.
JACC. Heart Failure|July 17, 2017
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart FailureBoback Ziaeian, Gregg C Fonarow, Paul A Heidenreich
JAMA Cardiology|November 3, 2021
National Trends in Heart Failure Hospitalization and Readmissions Associated With Policy Changes-ReplyManyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian
Heart Failure Clinics|October 10, 2022
SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical BenefitsNeal M Dixit, Boback Ziaeian, Gregg C Fonarow
Cardiac Failure Review|December 24, 2021
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection FractionNicholas K Brownell, Boback Ziaeian, Gregg C Fonarow
Journal of the American Heart Association|October 19, 2019
Association of Hospital Racial Composition and Payer Mix With Mortality in Acute Coronary SyndromePratyaksh K Srivastava, Gregg C Fonarow, Ehete Bahiru, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
JACC. Heart Failure|October 4, 2024
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2021Manyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian
JACC. Asia|November 7, 2022
Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection FractionNicholas K Brownell, Boback Ziaeian, Gregg C Fonarow
JACC. Heart Failure|October 17, 2017
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future DirectionsJeffrey J Hsu, Boback Ziaeian, Gregg C Fonarow
JAMA Cardiology|February 10, 2021
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2017Manyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian
Current Diabetes Reports|January 25, 2016
The 2013 ACC/AHA Cholesterol Treatment Guidelines: Applicability to Patients with DiabetesBoback Ziaeian, John Dinkler, Yuanlin Guo, et al.
JACC. Heart Failure|July 17, 2017
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart FailureBoback Ziaeian, Gregg C Fonarow, Paul A Heidenreich
JAMA Cardiology|November 3, 2021
National Trends in Heart Failure Hospitalization and Readmissions Associated With Policy Changes-ReplyManyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian
Heart Failure Clinics|October 10, 2022
SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical BenefitsNeal M Dixit, Boback Ziaeian, Gregg C Fonarow
Cardiac Failure Review|December 24, 2021
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection FractionNicholas K Brownell, Boback Ziaeian, Gregg C Fonarow
Journal of the American Heart Association|October 19, 2019
Association of Hospital Racial Composition and Payer Mix With Mortality in Acute Coronary SyndromePratyaksh K Srivastava, Gregg C Fonarow, Ehete Bahiru, et al.
Pageof 13